Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Repasky

Showing results (291-300 of 355) with videos related to

Pageof 36
Sort By:
Cancer Medicine|February 24, 2026
Hospitalist Care for Unplanned Oncology Admissions: A Mixed-Method Analysis of Oncology and General Hospitalist Outcomes and ProcessesMegan A Mullins, Sanah Ladhani, Abril Carrillo, et al.
JAMA Network Open|May 15, 2025
Digital Health Technology Use Among Spanish Speakers in the US: A Scoping ReviewRobin T Higashi, Bhaskar Thakur, Emily C Repasky, et al.
Cancer Immunity|February 14, 2006
Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancerYoshihiro Watanabe, Stephen LePage, Mark Elliott, et al.
Plos One|March 21, 2015
Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cellsBenjamin J Povinelli, Kathleen M Kokolus, Jason W-L Eng, et al.
Journal of Chemical Theory and Computation|April 6, 2023
Epik: p<i>K</i><sub>a</sub> and Protonation State Prediction through Machine LearningRyne C Johnston, Kun Yao, Zachary Kaplan, et al.
Scientific Reports|May 15, 2025
Chronic rejection models for vascularized composite tissue allotransplantationDaniel T Fisher, Emily Mackey, Eugene Kononov, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Prognostic immune markers in esophageal cancer patients managed with trimodal therapyMark K Farrugia, Elizabeth A Repasky, Minhui Chen, et al.
Journal of Medicinal Chemistry|April 8, 2016
WScore: A Flexible and Accurate Treatment of Explicit Water Molecules in Ligand-Receptor DockingRobert B Murphy, Matthew P Repasky, Jeremy R Greenwood, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapyMinhui Chen, Craig M Brackett, Lyudmila G Burdelya, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
Pageof 36

Showing results (291-300 of 355) with videos related to

Sort By:
Pageof 36
Cancer Medicine|February 24, 2026
Hospitalist Care for Unplanned Oncology Admissions: A Mixed-Method Analysis of Oncology and General Hospitalist Outcomes and ProcessesMegan A Mullins, Sanah Ladhani, Abril Carrillo, et al.
JAMA Network Open|May 15, 2025
Digital Health Technology Use Among Spanish Speakers in the US: A Scoping ReviewRobin T Higashi, Bhaskar Thakur, Emily C Repasky, et al.
Cancer Immunity|February 14, 2006
Characterization of preexisting humoral immunity specific for two cancer-testis antigens overexpressed at the mRNA level in non-small cell lung cancerYoshihiro Watanabe, Stephen LePage, Mark Elliott, et al.
Plos One|March 21, 2015
Standard sub-thermoneutral caging temperature influences radiosensitivity of hematopoietic stem and progenitor cellsBenjamin J Povinelli, Kathleen M Kokolus, Jason W-L Eng, et al.
Journal of Chemical Theory and Computation|April 6, 2023
Epik: p<i>K</i><sub>a</sub> and Protonation State Prediction through Machine LearningRyne C Johnston, Kun Yao, Zachary Kaplan, et al.
Scientific Reports|May 15, 2025
Chronic rejection models for vascularized composite tissue allotransplantationDaniel T Fisher, Emily Mackey, Eugene Kononov, et al.
Cancer Immunology, Immunotherapy : CII|January 3, 2025
Prognostic immune markers in esophageal cancer patients managed with trimodal therapyMark K Farrugia, Elizabeth A Repasky, Minhui Chen, et al.
Journal of Medicinal Chemistry|April 8, 2016
WScore: A Flexible and Accurate Treatment of Explicit Water Molecules in Ligand-Receptor DockingRobert B Murphy, Matthew P Repasky, Jeremy R Greenwood, et al.
Cancer Immunology, Immunotherapy : CII|January 13, 2021
Stimulation of an anti-tumor immune response with "chromatin-damaging" therapyMinhui Chen, Craig M Brackett, Lyudmila G Burdelya, et al.
Journal of Hepatology|August 13, 2011
Dual targeting of mTORC1/C2 complexes enhances histone deacetylase inhibitor-mediated anti-tumor efficacy in primary HCC cancer in vitro and in vivoHuanjie Shao, Chun Gao, Haikuo Tang, et al.
Pageof 36